These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9581851)

  • 1. Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.
    Knudsen ES; Pazzagli C; Born TL; Bertolaet BL; Knudsen KE; Arden KC; Henry RR; Feramisco JR
    Cancer Res; 1998 May; 58(9):2042-9. PubMed ID: 9581851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p21WAF1 expression induced by MEK/ERK pathway activation or inhibition correlates with growth arrest, myogenic differentiation and onco-phenotype reversal in rhabdomyosarcoma cells.
    Ciccarelli C; Marampon F; Scoglio A; Mauro A; Giacinti C; De Cesaris P; Zani BM
    Mol Cancer; 2005 Dec; 4():41. PubMed ID: 16351709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutation of Thr115 in MyoD positively regulates function in murine fibroblasts and human rhabdomyosarcoma cells.
    Liu LN; Dias P; Houghton PJ
    Cell Growth Differ; 1998 Sep; 9(9):699-711. PubMed ID: 9751114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myostatin inhibits rhabdomyosarcoma cell proliferation through an Rb-independent pathway.
    Langley B; Thomas M; McFarlane C; Gilmour S; Sharma M; Kambadur R
    Oncogene; 2004 Jan; 23(2):524-34. PubMed ID: 14724580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MyoD induces apoptosis in the absence of RB function through a p21(WAF1)-dependent re-localization of cyclin/cdk complexes to the nucleus.
    Peschiaroli A; Figliola R; Coltella L; Strom A; Valentini A; D'Agnano I; Maione R
    Oncogene; 2002 Nov; 21(53):8114-27. PubMed ID: 12444547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of c-Myc following MEK/ERK inhibition halts the expression of malignant phenotype in rhabdomyosarcoma and in non muscle-derived human tumors.
    Marampon F; Ciccarelli C; Zani BM
    Mol Cancer; 2006 Aug; 5():31. PubMed ID: 16899113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
    Ehmann GL; McLean TI; Bachenheimer SL
    Virology; 2000 Feb; 267(2):335-49. PubMed ID: 10662629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p27Kip1: a key mediator of retinoic acid induced growth arrest in the SMS-KCNR human neuroblastoma cell line.
    Matsuo T; Thiele CJ
    Oncogene; 1998 Jun; 16(25):3337-43. PubMed ID: 9681834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.
    Sirri V; Leibovitch MP; Leibovitch SA
    Oncogene; 2003 Aug; 22(36):5658-66. PubMed ID: 12944914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
    Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
    Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
    Yin F; Giuliano AE; Law RE; Van Herle AJ
    Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cAMP effects on myogenic gene expression in rhabdomyosarcoma cells.
    Wasserman LM; Newsham I; Huang HJ; Cavenee WK
    Exp Cell Res; 1996 Aug; 227(1):55-62. PubMed ID: 8806451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of myogenic differentiation program in cultured normal postmitotic mononucleated myoblasts and the aberrant differentiation in rhabdomyosarcoma cells].
    Lin ZX; Zhang ZQ; Han YL; Zhou LX; Mei HL; Holtzer H
    Shi Yan Sheng Wu Xue Bao; 1994 Mar; 27(1):79-89. PubMed ID: 8042410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ara-C treatment leads to differentiation and reverses the transformed phenotype in a human rhabdomyosarcoma cell line.
    Crouch GD; Kalebic T; Tsokos M; Helman LJ
    Exp Cell Res; 1993 Feb; 204(2):210-6. PubMed ID: 8440318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maduramicin inhibits proliferation and induces apoptosis in myoblast cells.
    Chen X; Gu Y; Singh K; Shang C; Barzegar M; Jiang S; Huang S
    PLoS One; 2014; 9(12):e115652. PubMed ID: 25531367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Opposing early and late effects of insulin-like growth factor I on differentiation and the cell cycle regulatory retinoblastoma protein in skeletal myoblasts.
    Rosenthal SM; Cheng ZQ
    Proc Natl Acad Sci U S A; 1995 Oct; 92(22):10307-11. PubMed ID: 7479773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase.
    Skapek SX; Rhee J; Spicer DB; Lassar AB
    Science; 1995 Feb; 267(5200):1022-4. PubMed ID: 7863328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical role played by cyclin D3 in the MyoD-mediated arrest of cell cycle during myoblast differentiation.
    Cenciarelli C; De Santa F; Puri PL; Mattei E; Ricci L; Bucci F; Felsani A; Caruso M
    Mol Cell Biol; 1999 Jul; 19(7):5203-17. PubMed ID: 10373569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological and molecular characterization of spontaneous myogenic differentiation in a human rhabdomyosarcoma cell line.
    Shapiro DN; Houghton PJ; Hazelton BJ; Germain GS; Murti KG; Rahman A; Houghton JA
    Cancer Res; 1990 Sep; 50(18):6002-9. PubMed ID: 2203524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of memory, differentiation, and repression of c-myc and p53 genes in human RD/TE-671 cells induced by a ureido-derivative of pyridine (UDP-4).
    Pappas IS; Sophianos D; Tzartos S; Tsiftsoglou AS
    Cell Growth Differ; 1996 Jun; 7(6):797-809. PubMed ID: 8780893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.